Cargando…

The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey

INTRODUCTION: In 2017, amidst insecurity and displacements posed by Boko Haram armed insurgency, cholera outbreak started in the Muna Garage camp for Internally Displaced Persons (IDPs) in Borno State, Nigeria. In response, the Borno Ministry of Health and partners determined to provide oral cholera...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngwa, Moise Chi, Alemu, Wondimagegnehu, Okudo, Ifeanyi, Owili, Collins, Ugochukwu, Uzoma, Clement, Peter, Devaux, Isabelle, Pezzoli, Lorenzo, Oche, James Agada, Ihekweazu, Chikwe, Sack, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326259/
https://www.ncbi.nlm.nih.gov/pubmed/32601092
http://dx.doi.org/10.1136/bmjgh-2020-002431
_version_ 1783552313930022912
author Ngwa, Moise Chi
Alemu, Wondimagegnehu
Okudo, Ifeanyi
Owili, Collins
Ugochukwu, Uzoma
Clement, Peter
Devaux, Isabelle
Pezzoli, Lorenzo
Oche, James Agada
Ihekweazu, Chikwe
Sack, David A
author_facet Ngwa, Moise Chi
Alemu, Wondimagegnehu
Okudo, Ifeanyi
Owili, Collins
Ugochukwu, Uzoma
Clement, Peter
Devaux, Isabelle
Pezzoli, Lorenzo
Oche, James Agada
Ihekweazu, Chikwe
Sack, David A
author_sort Ngwa, Moise Chi
collection PubMed
description INTRODUCTION: In 2017, amidst insecurity and displacements posed by Boko Haram armed insurgency, cholera outbreak started in the Muna Garage camp for Internally Displaced Persons (IDPs) in Borno State, Nigeria. In response, the Borno Ministry of Health and partners determined to provide oral cholera vaccine (OCV) to about 1 million people in IDP camps and surrounding communities in six Local Government Areas (LGAs) including Maiduguri, Jere, Konduga, Mafa, Dikwa, and Monguno. As part of Monitoring and Evaluation, we described the coverage achieved, adverse events following immunisation (AEFI), non-vaccination reasons, vaccination decisions as well as campaign information sources. METHODS: We conducted two-stage probability cluster surveys with clusters selected without replacement according to probability-proportionate-to-population-size in the six LGAs targeted by the campaign. Individuals aged ≥1 years were the eligible study population. Data sources were household interviews with vaccine card verification and memory recall, if no card, as well as multiple choice questions with an open-ended option. RESULTS: Overall, 12 931 respondents participated in the survey. Overall, 90% (95% CI: 88 to 92) of the target population received at least one dose of OCV, range 87% (95% CI: 75 to 94) in Maiduguri to 94% (95% CI: 88 to 97) in Monguno. The weighted two-dose coverage was 73% (95% CI: 68 to 77) with a low of 68% (95% CI: 46 to 86) in Maiduguri to a high of 87% (95% CI: 74 to 95) in Dikwa. The coverage was lower during first round (76%, 95% CI: 71 to 80) than second round (87%, 95% CI: 84 to 89) and ranged from 72% (95% CI: 42 to 89) and 82% (95% CI: 82 to 91) in Maiduguri to 87% (95% CI: 75 to 95) and 94% (95% CI: 88 to 97) in Dikwa for the respective first and second rounds. Also, coverage was higher among females of age 5 to 14 and ≥15 years than males of same age groups. There were mild AEFI with the most common symptoms being fever, headache and diarrhoea occurring up to 48 hours after ingesting the vaccine. The most common actions taken after AEFI symptoms included ‘did nothing’ and ‘self-medicated at home’. The top reason for taking vaccine was to protect from cholera while top reason for non-vaccination was travel/work. The main source of campaign information was a neighbour. An overwhelming majority (96%, 95% CI: 95% to 98%) felt the campaign team treated them with respect. While 43% (95% CI: 36% to 50%) asked no questions, 37% (95% CI: 31% to 44%) felt the team addressed all their concerns. CONCLUSION: The campaign achieved high coverage using door-to-door and fixed sites strategies amidst insecurity posed by Boko Haram. Additional studies are needed to improve how to reduce non-vaccination, especially for the first round. While OCV provides protection for a few years, additional actions will be needed to make investments in water, sanitation and hygiene infrastructure.
format Online
Article
Text
id pubmed-7326259
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-73262592020-07-02 The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey Ngwa, Moise Chi Alemu, Wondimagegnehu Okudo, Ifeanyi Owili, Collins Ugochukwu, Uzoma Clement, Peter Devaux, Isabelle Pezzoli, Lorenzo Oche, James Agada Ihekweazu, Chikwe Sack, David A BMJ Glob Health Original Research INTRODUCTION: In 2017, amidst insecurity and displacements posed by Boko Haram armed insurgency, cholera outbreak started in the Muna Garage camp for Internally Displaced Persons (IDPs) in Borno State, Nigeria. In response, the Borno Ministry of Health and partners determined to provide oral cholera vaccine (OCV) to about 1 million people in IDP camps and surrounding communities in six Local Government Areas (LGAs) including Maiduguri, Jere, Konduga, Mafa, Dikwa, and Monguno. As part of Monitoring and Evaluation, we described the coverage achieved, adverse events following immunisation (AEFI), non-vaccination reasons, vaccination decisions as well as campaign information sources. METHODS: We conducted two-stage probability cluster surveys with clusters selected without replacement according to probability-proportionate-to-population-size in the six LGAs targeted by the campaign. Individuals aged ≥1 years were the eligible study population. Data sources were household interviews with vaccine card verification and memory recall, if no card, as well as multiple choice questions with an open-ended option. RESULTS: Overall, 12 931 respondents participated in the survey. Overall, 90% (95% CI: 88 to 92) of the target population received at least one dose of OCV, range 87% (95% CI: 75 to 94) in Maiduguri to 94% (95% CI: 88 to 97) in Monguno. The weighted two-dose coverage was 73% (95% CI: 68 to 77) with a low of 68% (95% CI: 46 to 86) in Maiduguri to a high of 87% (95% CI: 74 to 95) in Dikwa. The coverage was lower during first round (76%, 95% CI: 71 to 80) than second round (87%, 95% CI: 84 to 89) and ranged from 72% (95% CI: 42 to 89) and 82% (95% CI: 82 to 91) in Maiduguri to 87% (95% CI: 75 to 95) and 94% (95% CI: 88 to 97) in Dikwa for the respective first and second rounds. Also, coverage was higher among females of age 5 to 14 and ≥15 years than males of same age groups. There were mild AEFI with the most common symptoms being fever, headache and diarrhoea occurring up to 48 hours after ingesting the vaccine. The most common actions taken after AEFI symptoms included ‘did nothing’ and ‘self-medicated at home’. The top reason for taking vaccine was to protect from cholera while top reason for non-vaccination was travel/work. The main source of campaign information was a neighbour. An overwhelming majority (96%, 95% CI: 95% to 98%) felt the campaign team treated them with respect. While 43% (95% CI: 36% to 50%) asked no questions, 37% (95% CI: 31% to 44%) felt the team addressed all their concerns. CONCLUSION: The campaign achieved high coverage using door-to-door and fixed sites strategies amidst insecurity posed by Boko Haram. Additional studies are needed to improve how to reduce non-vaccination, especially for the first round. While OCV provides protection for a few years, additional actions will be needed to make investments in water, sanitation and hygiene infrastructure. BMJ Publishing Group 2020-06-29 /pmc/articles/PMC7326259/ /pubmed/32601092 http://dx.doi.org/10.1136/bmjgh-2020-002431 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Ngwa, Moise Chi
Alemu, Wondimagegnehu
Okudo, Ifeanyi
Owili, Collins
Ugochukwu, Uzoma
Clement, Peter
Devaux, Isabelle
Pezzoli, Lorenzo
Oche, James Agada
Ihekweazu, Chikwe
Sack, David A
The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey
title The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey
title_full The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey
title_fullStr The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey
title_full_unstemmed The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey
title_short The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey
title_sort reactive vaccination campaign against cholera emergency in camps for internally displaced persons, borno, nigeria, 2017: a two-stage cluster survey
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326259/
https://www.ncbi.nlm.nih.gov/pubmed/32601092
http://dx.doi.org/10.1136/bmjgh-2020-002431
work_keys_str_mv AT ngwamoisechi thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT alemuwondimagegnehu thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT okudoifeanyi thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT owilicollins thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT ugochukwuuzoma thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT clementpeter thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT devauxisabelle thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT pezzolilorenzo thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT ochejamesagada thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT ihekweazuchikwe thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT sackdavida thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT ngwamoisechi reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT alemuwondimagegnehu reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT okudoifeanyi reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT owilicollins reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT ugochukwuuzoma reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT clementpeter reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT devauxisabelle reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT pezzolilorenzo reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT ochejamesagada reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT ihekweazuchikwe reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey
AT sackdavida reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey